Sickle cell disease: a chronic inflammatory condition

被引:53
作者
Chies, JAB [1 ]
Nardi, NB [1 ]
机构
[1] Univ Fed Rio Grande Sul, Dept Genet, Immunogenet Lab, BR-91501970 Porto Alegre, RS, Brazil
关键词
D O I
10.1054/mehy.2000.1310
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Homozygous sickle cell disease (SCD) has a wide spectrum of clinical manifestations which varies from an almost asymptomatic condition to severe illness, despite the fact that all subjects with this disease have the same base change in their DNA. The source of this variation is partly environmental, but a large part of this variability can derive from the presence of genetic modulators which are not fully understood. It was postulated that some degree of immunodeficiency should be associated with this condition, but no deficiency, directly related to a given component of the immune system, was observed that could explain the high levels of recurrent infections presented by sickle cell disease patients. Reviewing data from the literature we:suggest that the influence of the immune system in the variation of clinical manifestations presented by SCD patients is not related with any immunodeficiency but is rather the result of a chronic inflammatory condition. (C) 2001 Harcourt Publishers Ltd.
引用
收藏
页码:46 / 50
页数:5
相关论文
共 26 条
[1]   LEUKOCYTE COUNTS IN CHILDREN WITH SICKLE-CELL DISEASE - COMPARATIVE VALUES IN STEADY-STATE, VASO-OCCLUSIVE CRISIS, AND BACTERIAL-INFECTION [J].
BUCHANAN, GR ;
GLADER, BE .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1978, 132 (04) :396-398
[2]   (±)-trans-2-[3-methoxy-4-(4-chlorophenylthioethoxy)-5-(N-methyl-N-hydroxyureidyl)methylphenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran (CMI-392), a potent dual 5-lipoxygenase inhibitor and platelet-activating factor receptor antagonist [J].
Cai, XO ;
Scannell, RT ;
Yaeger, D ;
Hussoin, MS ;
Killian, DB ;
Qian, CG ;
Eckman, J ;
Hwang, SB ;
Libertine-Garahan, L ;
Yeh, CG ;
Ip, SH ;
Shen, TY .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (11) :1970-1979
[3]  
CHIES JAB, 1999, GENET MOL BIOL, V22, P738
[4]   N-hydroxyurea and hydroxamic acid inhibitors of cyclooxygenase and 5-lipoxygenase [J].
Connolly, PJ ;
Wetter, SK ;
Beers, KN ;
Hamel, SC ;
Chen, RHK ;
Wachter, MP ;
Ansell, J ;
Singer, MM ;
Steber, M ;
Ritchie, DM ;
Argentieri, DC .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (07) :979-984
[5]  
Croizat H, 1999, AM J HEMATOL, V60, P105, DOI 10.1002/(SICI)1096-8652(199902)60:2<105::AID-AJH4>3.0.CO
[6]  
2-Z
[7]   RECURRENT INFECTIONS IN SICKLE-CELL DISEASE - HEMATOLOGICAL AND IMMUNE STUDIES [J].
DECEULAER, K ;
PAGLIUCA, A ;
FORBES, M ;
MAUDE, GH ;
SERJEANT, BE ;
SERJEANT, GR .
CLINICA CHIMICA ACTA, 1985, 148 (03) :161-165
[8]   HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5 [J].
Dragic, T ;
Litwin, V ;
Allaway, GP ;
Martin, SR ;
Huang, YX ;
Nagashima, KA ;
Cayanan, C ;
Maddon, PJ ;
Koup, RA ;
Moore, JP ;
Paxton, WA .
NATURE, 1996, 381 (6584) :667-673
[9]   Genetic mapping of a murine locus controlling development of T helper 1 T helper 2 type responses [J].
Gorham, JD ;
Guler, ML ;
Steen, RG ;
Mackey, AJ ;
Daly, MJ ;
Frederick, K ;
Dietrich, WF ;
Murphy, KM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (22) :12467-12472
[10]   Anti-inflammatory effects of zileuton in a subpopulation of allergic asthmatics [J].
Hasday, JD ;
Meltzer, SS ;
Moore, WC ;
Wisniewski, P ;
Hebel, JR ;
Lanni, C ;
Dubé, LM ;
Bleecker, ER .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 161 (04) :1229-1236